PDCD1 and esophageal cancer: The enrichment pathway of neutrophil subsets in the resistant group was also related to type I interferon, and was related to the chemotaxis of neutrophils and DCs, which may play a synergistic role with monocytes in the PD-1 mMAB resistant of esophageal cancer.